About
Promentis Pharmaceuticals, Inc. is a privately-held biopharmaceutical company developing novel oral therapies targeting neuropsychiatric disorders, with an initial focus on trichotillomania, a disorder with no approved treatments.
Explore Promentis Pharmaceuticals, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.